trending Market Intelligence /marketintelligence/en/news-insights/trending/gHywRAKRLjJ48KxS8ZTXmw2 content esgSubNav
In This List

Aldeyra plans $20M 'at the market' offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Aldeyra plans $20M 'at the market' offering

Aldeyra Therapeutics Inc. plans to sell up to $20 million of its common stock from time to time via an "at the market" offering.

Cantor Fitzgerald & Co. will act as agent for the offering, as part of a controlled equity offering sales agreement with Aldeyra Therapeutics.